Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06712849 · ClinicalTrials.gov registry record · NA

Noninvasive Brain Stimulation in Adult Amblyopia

A NA study of Amblyopia, sponsored by Midwestern University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06712849 is a NA study of Amblyopia that is actively recruiting participants, run by Midwestern University. The registered enrollment target is 60 participants, below the 163-participant average among 24 other Amblyopia trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06712849, a NA study of Amblyopia, is actively recruiting participants, sponsored by Midwestern University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized controlled trial is to investigate the effectiveness of non-invasive brain stimulation in treating adults with amblyopia. The main questions it aims to answer are: 1. What are the effects of non-invasive brain stimulation on neuronal plasticity in the visual cortex of adults with amblyopia, and does it produce lasting changes? 2. Do cumulative sessions of non-invasive brain stimulation influence neural plasticity and higher-order visual functions in adults with amblyopia? The investigators hypothesize that non-invasive brain stimulation will show a positive cumulative effect after five (5) consecutive days of stimulation on visual perception and function in adults with amblyopia. Participants will be randomized into one of two treatment groups: 1. High-frequency transcranial random noise stimulation (hf-tRNS). 2. Sham stimulation. Researchers will compare baseline measurements of crowded visual acuity, contrast sensitivity, stereoacuity, phosphene thresholds, global motion perception, form pattern recognition and pattern-reversal visual evoked potentials (VEPs) to post-treatment measurements for each group.

Conditions Studied

Amblyopia

Interventions

  • DEVICE Sham Transcranial Random Noise Stimulation
  • DEVICE High Frequency Transcranial Random Noise Stimulation

Study Locations (1)

Illinois

  • Midwestern University Eye Institute - Downers Grove

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-05-01
Est. Completion 2028-12-31
Phase NA

Sponsor

Midwestern University

15 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06712849

The ClinicalTrials.gov registry entry for NCT06712849 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 163-participant average among 24 other Amblyopia trials with a reported enrollment target (63% lower). The listed sponsor is Midwestern University, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which Sham Transcranial Random Noise Stimulation is the first listed.

NCT06712849 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06712849 about?

NCT06712849 is a clinical study titled "Noninvasive Brain Stimulation in Adult Amblyopia". The goal of this randomized controlled trial is to investigate the effectiveness of non-invasive brain stimulation in treating adults with amblyopia. The main questions it aims to answer are: 1. What are the effects of non-invasive brain stimulation on neuronal plasticity in the visual cortex of ad...

What is the current status of trial NCT06712849?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-05-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06712849 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT06712849?

The interventions under investigation include: Sham Transcranial Random Noise Stimulation (DEVICE), High Frequency Transcranial Random Noise Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06712849?

This trial is sponsored by Midwestern University, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06712849 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amblyopia

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.